Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för tyloxapol. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

11 träffar

Bibliografisk träff 2018-09-04

Pharmacological evaluation of Convolvulus pluricaulis as hypolipidaemic agent in Triton WR-1339-induced hyperlipidaemia in rats.

Garg G, Patil A, Singh J, Kaushik N, Praksah A, Pal A, Chakrabarti A.

J Pharm Pharmacol · comparative study; journal article · DOI 10.1111/jphp.13004

Bibliografisk träff 2018-01-01

Synthesis and in Vivo Lipid-Lowering Activity of Novel Imidazoles-5-carboxamide Derivatives in Triton-WR-1339-Induced Hyperlipidemic Wistar Rats.

Jasim SH, Abu Sheikha GM, Abuzaid HM, Al-Qirim TM, Shattat GF, Sabbah DA, Ata, Ala SA, Aboumair MS, Sweidan KA, Bkhaitan MM.

Chem Pharm Bull (Tokyo) · journal article · DOI 10.1248/cpb.c18-00346

Bibliografisk träff 2017-09-21

Hypolipidemic activity of P-methoxycinnamic diester (PCO-C) isolated from Copernicia prunífera against Triton WR-1339 and hyperlipidemic diet in mice.

Filho ACVA, Rodrigues PAS, Benjamin SR, Paim RTT, Holanda MO, Silva JYG, Milo TS, Vieira IGP, Queiroz MGR, Guedes MIF.

Environ Toxicol Pharmacol · journal article · DOI 10.1016/j.etap.2017.09.015

Bibliografisk träff 2017-07-03

Evaluation of DNA damage in Wistar rat tissues with hyperlipidemia induced by tyloxapol.

de Sousa JA, Pereira P, Allgayer MDC, Marroni NP, de Barros Falcão Ferraz A, Picada JN.

Exp Mol Pathol · journal article · DOI 10.1016/j.yexmp.2017.06.009

Bibliografisk träff 2017-04-21

Enzymes that hydrolyze adenine nucleotides in a model of hypercholesterolemia induced by Triton WR-1339: protective effects of β-caryophyllene.

Baldissera MD, Souza CF, Doleski PH, Leal DBR, Stefani LM, Boligon AA, Monteiro SG.

Mol Cell Biochem · journal article · DOI 10.1007/s11010-017-3042-9

Bibliografisk träff 2016-08-25

Lipid lowering activity of novel N-(benzoylphenyl)pyridine-3-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats.

Abu Farha R, Bustanji Y, Al-Hiari Y, Al-Qirim T, Abu Shiekha G, Albashiti R.

J Enzyme Inhib Med Chem · journal article · DOI 10.1080/14756366.2016.1222581

Bibliografisk träff 2016-06-16

Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial.

Koppitz M, Eschenburg C, Salzmann E, Rosewich M, Schubert R, Zielen S.

PLoS One · research-article; randomized controlled trial; journal article · DOI 10.1371/journal.pone.0156999

Bibliografisk träff 2016-06-01

The Long Term Kinetic of Plasma Lipids and Lipoproteins in Tyloxapol Injected Rats.

Rasouli M, Tahmouri H, Mosavi-Mehr M.

J Clin Diagn Res · other; journal article · DOI 10.7860/jcdr/2016/18890.7993

Bibliografisk träff 2016-03-08

Influence of the Surfactant Tyloxapol on Mucociliary Clearance in Human Respiratory Cystic Fibrosis Cells.

Beubler E, Fischer R, Untersteiner G, Strohmaier W.

Pharmacology · journal article · DOI 10.1159/000444589

Bibliografisk träff 2014-09-03

Tyloxapol niosomes as prospective drug delivery module for antiretroviral drug nevirapine.

Mehta SK, Jindal N.

AAPS PharmSciTech · research support, non-u.s. gov't; research-article; journal article · DOI 10.1208/s12249-014-0183-y

Bibliografisk träff 2006-06-21

Cytotoxic properties of tyloxapol.

Kuo JH, Jan MS, Chiu HW.

Pharm Res · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1007/s11095-006-0281-y